| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 39.669 | 66.849 | 103.698 | 118.411 | 150.257 | 164.449 | 214.814 | 288.204 | 347.409 | 417.464 |
| Total Income - EUR | 39.669 | 66.849 | 103.698 | 118.411 | 150.257 | 168.357 | 214.814 | 288.457 | 347.410 | 418.193 |
| Total Expenses - EUR | 34.493 | 52.641 | 53.846 | 84.725 | 117.795 | 134.919 | 206.103 | 266.690 | 312.672 | 391.018 |
| Gross Profit/Loss - EUR | 5.176 | 14.207 | 49.852 | 33.685 | 32.462 | 33.439 | 8.711 | 21.767 | 34.737 | 27.174 |
| Net Profit/Loss - EUR | 3.986 | 13.539 | 48.815 | 32.501 | 30.959 | 31.914 | 6.821 | 18.940 | 31.680 | 22.970 |
| Employees | 4 | 4 | 3 | 4 | 5 | 5 | 5 | 4 | 4 | 6 |
Check the financial reports for the company - Neuroptics Cris Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 2.405 | 5.131 | 22.593 | 39.304 | 32.872 | 30.410 | 24.572 | 27.635 |
| Current Assets | 7.189 | 14.335 | 47.482 | 31.414 | 14.337 | 16.420 | 27.727 | 59.721 | 48.206 | 30.357 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 173 | 172 |
| Receivables | 2.755 | 1.900 | 1.868 | 18.528 | 3.229 | 1.859 | 6.194 | 41.520 | 13.575 | 1.516 |
| Cash | 4.434 | 12.435 | 45.614 | 12.886 | 11.108 | 14.560 | 21.533 | 18.201 | 34.458 | 28.669 |
| Shareholders Funds | 5.785 | 13.588 | 48.867 | 32.553 | 31.010 | 48.234 | 53.985 | 18.993 | 37.735 | 37.925 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.404 | 966 | 1.286 | 4.297 | 6.500 | 7.767 | 6.959 | 71.139 | 35.042 | 20.067 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuroptics Cris Srl